The tweet was deleted by the author.
But we saved everything 🙂.
NeuroPace Inc announced that DHR Health has completed its first implant of the RNS System, introducing advanced responsive neurostimulation therapy to the Rio Grande Valley.
This development expands access to highly specialized epilepsy care for patients in the region, where options for advanced neurological treatment have previously been limited. By leveraging the RNS System, DHR Health aims to improve outcomes for those living with epilepsy who may not have responded to conventional therapies. The milestone marks a meaningful advancement in the availability of innovative medical technology in underserved areas.
NeuroPace previously reported a 62 percent median seizure reduction at six months for focal epilepsy patients in its largest FDA-reviewed study. The company has also noted that patients preferred the RNS System over VNS for its more targeted and immediate seizure control capabilities, according to comparative findings. These results have supported broader adoption of the device in clinical settings.